Navigation Links
Astaxanthin Stability Breakthrough Achieved by Valensa
Date:8/19/2009

ORLANDO, Fla., Aug. 19 /PRNewswire/ -- Valensa International announced today that it has developed technology that has dramatically increased the stability and shelf-life of the powerful, versatile antioxidant astaxanthin. The company has just completed a 7-year shelf-life study of its Zanthin(R) natural astaxanthin that indicates that this ultra-high pressure supercritical CO2 extract of Haematococcus pluvialis, bolstered by Valensa's proprietary O2B(R) Peroxidation Blocker technology, has a minimum 4-year shelf-life. Published reports by other astaxanthin producers indicate ranges of 1 - 2 years under refrigeration as the existing state-of-the-art for astaxanthin stability. Effective immediately, Valensa has raised its Zanthin(R) brand astaxanthin oleoresin stability recommendation to 4 years at 20 degrees C. The greater stability profile of Zanthin(R) astaxanthin will allow formulators of nutraceutical products to use smaller safety margins (overage) to assure consumers of efficacy in products on a store shelf, which can lead to cost savings.

According to Rudi E. Moerck, President & CEO of Valensa International, it is incumbent on producers of nutraceutical ingredients to manage the stability issues of their extracted products to assure safety and quality. "Anytime you extract oils or oleoresins from natural materials, you are faced with stability issues relating to oxidative degradation. At Valensa, we have developed a considerable body of expertise in addressing the stability of our extracted products, continually developing new extraction methodologies and developing customized stabilization packages that are natural and protect our products and the people who use them," he said. "The data in our just concluded study are a confirmation of why our customers put their trust in Zanthin(R) natural astaxanthin as the best and most stable astaxanthin ingredient on the market today. Essentially, we have been able to eliminate stability concerns and create a new level of astaxanthin shelf-life for our customers," he added. Moerck went on to point out that the company's position as a fully integrated supplier with chain of custody over raw materials growing and harvesting through the extraction process is the source for overall quality for its Zanthin(R) natural astaxanthin and contributes to the company's ability to manage shelf-life issues. Valensa now recommends a 5% safety margin, or "overage," for its astaxanthin as compared to the 10% the industry typically uses.

ZANTHIN(R) - A natural, high efficacy extract with proven quality

Valensa International is the world's leading manufacturer of finished form natural astaxanthin extract. It was the first company to have finished form material approved for use by regulatory agencies in both the United States and Europe. Valensa employs its proprietary DeepExtract(R) supercritical CO2 process to create the best quality materials and its O2B(R) Peroxidation Blocker stabilization technology to ensure long-term stability and efficacy for the consumer. The company employs dedicated organic certified facilities for the extraction of astaxanthin to ensure quality and avoid the potential for contamination by solvents or allergens that can occur when an astaxanthin extractor is also producing other products -- such as peanuts or shell-fish-based materials -- in the same equipment. Scientific studies of stability chemistry with extracted plant-derived oleoresins have allowed Valensa to move beyond ingredients such as safflower oil -- a diluent widely used in the industry and which that actually increases oxidative degradation -- to custom-tailored stabilization packages designed for the product in question.

For information on Zanthin(R) Natural Astaxanthin, please contact Valensa directly.

    For further information, contact:

    Rudi Moerck, President & CEO
    Voice: 352-357-2004
    Fax: 352-483-2095

This release was issued through eReleases(TM). For more information, visithttp://www.ereleases.com.


'/>"/>
SOURCE Valensa International, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Valensa and Parry Nutraceuticals Introduce Organic SpiruZan(TM) Spirulina/Astaxanthin Complex as Lifestyle Support for a Fast-Paced World
2. Valensa Completes Second Expansion of Astaxanthin Capacity
3. Smith & Nephew Endoscopys BIORAPTOR(TM) 2.3 PK Suture Anchor Provides Secure Repair for Shoulder, Hip Instability
4. Aon Study Finds Stability in Nationwide Liability Costs in the Long Term Health Care Sector
5. Effect of mutant p53 stability on tumorigenesis and drug design
6. Unique skeletal muscle design contributes to spine stability
7. National Front Line Caregiver Group Urges Senate Leaders to Support Grassley Amendment Protecting Seniors Care, Assuring Stability of Nations Long Term Care Workforce
8. Studies evaluate the anatomy and stability of ACL reconstruction with different techniques
9. External focus improves postural stability in patients with Parkinsons disease
10. Covance Expands Analytical and Stability Service Capacity in North America
11. Morehead Presents Webinar on Preventing Physician Disloyalty: Building Stability and Trust with 'At-Risk' Physicians
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Orion, Clarkston, Michigan (PRWEB) , ... June 26, ... ... with respect to fertility once they have been diagnosed with endometriosis. These women ... intercourse but they also require a comprehensive approach that can help for preservation ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/25/2016)... ... 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland ... iHire in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness ... & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016  In a startling report released today, ... residents by lacking a comprehensive, proven plan to eliminate prescription opioid ... ranking of how states are tackling the worst drug crisis in ... states – Kentucky , New Mexico ... . Of the 28 failing states, three – ...
(Date:6/23/2016)... , June 23, 2016 Research ... MEMS Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data ... analysis. Assessment of major trends with potential impact on the ... analysis of market segmentation which comprises of sub markets, regional ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... their offering. The current ... environment for MedImmune to enter. The US ageing population creates ... drive considerable growth for effective anti-influenza medications. The introduction of ... but development is still in its infancy. ...
Breaking Medicine Technology: